Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

被引：0
|
作者：
Dhakchinamoorthi Krishna Kumar
Deepak Gopal Shewade
Marie-Anne Loriot
Philippe Beaune
Jayaraman Balachander
B. V. Sai Chandran
Chandrasekaran Adithan
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Pharmacology
[2] INSERM UMRS 775,University Paris Sorbonne Cité
[3] Assistance Publique des Hôpitaux de Paris,Department of Biochemistry, Georges Pompidou European Hospital
[4] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiology
[5] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiothoracic and Vascular Surgery
来源：
European Journal of Clinical Pharmacology | 2014年 / 70卷
关键词：
Warfarin; Genotype; Polymorphisms; Pharmacogenetic algorithm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [1] Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population
    Kumar, Dhakchinamoorthi Krishna
    Shewade, Deepak Gopal
    Loriot, Marie-Anne
    Beaune, Philippe
    Balachander, Jayaraman
    Chandran, B. V. Sai
    Adithan, Chandrasekaran
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (01) : 47 - 56
  • [2] Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population
    Vear, Susan I.
    Ayers, Gregory D.
    Stein, C. Michael
    Ho, Richard H.
    BLOOD, 2012, 120 (21)
  • [3] Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population
    Giri, Anil K.
    Khan, Nazir M.
    Grover, Sandeep
    Kaur, Ismeet
    Basu, Analabha
    Tandon, Nikhil
    Scaria, Vinod
    Kukreti, Ritushree
    Brahmachari, Samir K.
    Bharadwaj, Dwaipayan
    PHARMACOGENOMICS, 2014, 15 (10) : 1337 - 1354
  • [4] Erratum to: Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients
    Takuya Wakamiya
    Tatsunori Hokosaki
    Shin-ichi Tsujimoto
    Keisuke Kadota
    Yusuke Nakano
    Shigeo Watanabe
    Mari Iwamoto
    Masakatsu Yanagimachi
    Shuichi Ito
    Molecular Diagnosis & Therapy, 2016, 20 : 501 - 501
  • [5] Impact of Genetic Factors (CYP2C9, VKORC1 and CYP4F2) on Warfarin Dose Requirement in the Turkish Population
    Ozer, Mahmut
    Demirci, Yeliz
    Hizel, Candan
    Sarikaya, Sabit
    Karalti, Iskender
    Kaspar, Cigdem
    Alpan, Serdar
    Genc, Ece
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (03) : 209 - 214
  • [6] Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey
    Kocael, Ahmet
    Eronat, Allison Pinar
    Tuzuner, Mete Bora
    Ekmekci, Ahmet
    Orhan, Ahmet Lutfullah
    Ikizceli, Ibrahim
    Yilmaz-Aydogan, Hulya
    Ozturk, Oguz
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (02) : 1825 - 1833
  • [7] Effect of CYP2C9, VKORC1, CYP4F2, and GGCX gene variants and patient characteristics on acenocoumarol maintenance dose: Proposal for a dosing algorithm for Moroccan patients
    Elkhazraji, Abdelhak
    Bouaiti, El Arbi
    Boulahyaoui, Hassan
    Nahmtchougli, Christiana Philippa
    Zahid, Hafid
    Bensaid, Mounia
    Ibrahimi, Azeddine
    Messaoudi, Nezha
    DRUG DISCOVERIES AND THERAPEUTICS, 2018, 12 (02): : 68 - 76
  • [8] Interpretation of the effect of CYP2C9, VKORC1 and CYP4F2 variants on warfarin dosing adjustment in Turkey
    Ahmet Kocael
    Allison Pınar Eronat
    Mete Bora Tüzüner
    Ahmet Ekmekçi
    Ahmet Lütfullah Orhan
    İbrahim İkizceli
    Hülya Yılmaz-Aydoğan
    Oğuz Öztürk
    Molecular Biology Reports, 2019, 46 : 1825 - 1833
  • [9] Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU
    Scott, Stuart A.
    Patel, Manishkumar
    Martis, Suparna
    Lubitz, Steven A.
    van der Zee, Sarina
    Yoo, Chang
    Edelmann, Lisa
    Halperin, Jonathan L.
    Desnick, Robert J.
    PHARMACOGENOMICS, 2012, 13 (03) : 297 - 307
  • [10] Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
    Rusdiana, T.
    Araki, T.
    Nakamura, T.
    Subarnas, A.
    Yamamoto, K.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) : 395 - 405
12345